Blood Biomarkers, Aducanumab and Setting Precedent for Dementia Care Advances
Brent Forester, MD, MSc, discusses the confluence of biomarker and disease-targeting therapy in Alzheimer's, and the need to appropriately introduce these tools.
Nora D. Volkow, MD: Combating COVID-Era Issues in Substance Use Disorder
The director of NIDA discusses the unprecedented impact of the pandemic on overdose deaths—and how substance use disorder care may still reach greater capability when all is said and done.
The Challenges to Identifying Dementia, Alzheimer-Risk Patients
Dementia and Alzheimer's disease cases are anticipated to boom in coming decades. One expert stressed the need for improved screening and facilitation of care at the earliest stages and signs.
Guiding Appropriate Ketamine, Esketamine Use in Psychiatry
The lead author of treatment recommendations weighs in on their current use and future research.
Taha Qazi, MD: Male Sexual Dysfunction Following Ulcerative Colitis Surgery
Patients who have IPAA are more than twice as likely to suffer from male sexual dysfunction.
How Evolving Psychiatric Definitions Set the Tone for Care
Amid significant psychotherapy innovation and consideration to broader aspects of mental illness definition, Jonathan Alpert, MD, PhD, emphasizes the need for improved clinical trial standards.
Adjunctive Cariprazine with Antidepressants Benefits Adult Major Depressive Disorder
New phase 3 data presented at APA 2022 support the agent as an adjunctive in older patients without benefit from monotherapy antidepressant medication.
How Mental Illness Definitions Are Still Being Uncovered and Refined
Montefiore psychiatry chair Jonathan Alpert, MD, PhD, discusses suggested updates to the DSM-5—with consideration to social determinants and patient-reported functioning.
The Pediatric Disaster Psychiatry Care Team
Linda Chokroverty, MD, discusses the significance of timing, communication and care coordination when children are affected by disasters or trauma.
Understanding Socially-Determined Mental Health and the Impact of COVID-19
APA president-elect Rebecca W. Brendel, MD, JD, discusses the need to prepare for a "twin mental health pandemic" while continuing to appropriately facilitate innovations in psychiatric care.
Zuranolone Benefits Major Depression, Postpartum Depression in Clinical Program
Anita Clayton, MD, reviews the available phase 2 and 3 clinical data for the novel, once-daily oral investigative drug.
The Need for Disaster Psychiatry Care
Linda Chokroverty, MD, discusses the role psychiatrists play in managing the mental health effects of disasters, and how children specifically may be impacted.
Eco-Anxiety and Contributing Mental Health Factors Among BIPOC
A pair of psychiatrists discuss how climate change and other social determinants of health are affecting the mental wellbeing of indigenous people.
Who Makes Up the Modern Dementia Care Team?
It takes even more than a village to provide the comprehensive care needed for aging, neurocognitive patients, says Rajesh R. Tampi, MD, MS.
The Developing Dementia Definition, Treatment Field
Rajesh R. Tampi, MD, MS, discusses the evolved definition of dementia as a cognitive disorder, and how its spectrum of symptoms impact clinical development.
Organizations Call on FDA To Help Address Recurrent C Difficile Burdens
Christian Lillis of the Peggy Lillis Foundation for C. Diff Education & Advocacy discusses the need for greater industry-organization support and drug development.
Kenneth Chapman, MD: Interpreting Global Perspectives on GINA Asthma Recommendations
Results from the 2 APPaRENT trials suggest regular inhaled corticosteroids/LABA alone or with short-acting beta agonists were the preferred treatment approach with physicians.
Bradley Richmond, MD, PhD: How Smoke Might Influence Ciliated Cell Function in COPD
Dr. Richmond speaks to the newest pulmonology data from Vanderbilt University that was presented at ATS 2022.
Al Rizzo, MD: Detailing the Latest Data on Pulmonary Health from ATS 2022
Dr. Rizzo sits down with HCPLive to discuss the impact of air pollution and allergies on pulmonary health, as well as new research on pulmonary arterial hypertension.
Tara Vijayan, MD: Doctors Fighting Misinformation
Dr. Tara Vijayan talks about how primary care physicians can be best combat misinformation.
Sanjiv Chopra, MD: Liver Disease During the COVID-19 Pandemic
Alcohol use increased during the COVID-19 pandemic, leading to an increase in alcoholic hepatitis.
Tara Vijayan, MD: Combating Drug Scarcity
High-risk individuals should be targeted when drug scarcity comes into play.
Tara Vijayan, MD: Targeting the Right Population for COVID-19 Treatments
There remains a need to develop more antivirals that can be easily scaled up for COVID-19.
How Viloxazine Extended-Release Capsules Alter Adult ADHD Care
Theresa R. Cerulli, MD, discusses the known clinical profile and evidential potential of the newest non-stimulant ADHD drug for adults.
Ty Gluckman, MD: Cardiovascular Concerns in 2022
There is concern for cardiovascular patients over missed screenings during the pandemic.
The Unique Signs and Struggles of Adult ADHD
On the heels of the FDA approval of viloxazine extended-release capsules for adult ADHD, a neuropsychiatrist discusses the state of care and diagnosis among older patients.
Pass The Study: An Injected Stem Cell for Patients with Geographic Atrophy
In the first episode of this new game show, a team of ARVO 2022 investigators work to invent an innovative clinical trial.
Anticipating the Ophthalmology Gene Therapy Pipeline
From curative stem cell approaches to in-clinic subretinal injections, Arshad Khanani, MD, MA, navigates what the future drug class may entail.
Preparing for the First Geographic Atrophy Therapies
An FDA decision could come as soon as this year. One expert stresses the need for improved screening, biomarker research, and patient communication beforehand.
Gene Therapy RGX-314 Benefits nAMD Treatment Burden in Phase 2 AAVIATE
Study author Arshad Khanani, MD, MA, discusses how the novel-targeting gene therapy candidate may uniquely benefit patients with treated retina disease.
2 Clarke Drive Cranbury, NJ 08512